Prolonged effects of adenoviral vector priming on T-cell cytokine production in heterologous adenoviral vector/mRNA COVID-19 vaccination regimens - Isogawa, Masanori; Onodera, Taishi; Ainai, Akira; Kotaki, Ryutaro; Kanno, Takayuki; Saito, Shinji; Tobiume, Minoru; Tokunaga, Kenzo; Hara, Megumi; Hirota, Yoshio; Suzuki, Tadaki; Takahashi, Yoshimasa; et al. (Scientific reports, 2025)
Keywords: 2019-nCoV Vaccine mRNA-1273 - immunology; 631/250; 692/308; Adenoviridae - genetics; Adenoviridae - immunology; Antibodies; Antibodies, Neutralizing - blood; Antibodies, Neutralizing - immunology; Antibodies, Viral - blood; Antibodies, Viral - immunology; BNT162 Vaccine - immunology; COVID-19; COVID-19 - immunology; COVID-19 - prevention & control; COVID-19 vaccines; COVID-19 Vaccines - administration & dosage; COVID-19 Vaccines - immunology; Cytokines; Cytokines - immunology; Cytokines - metabolism; Female; Genetic Vectors - genetics; Genetic Vectors - immunology; Humanities and Social Sciences; Humans; Immune imprinting; Immunization, Secondary; Immunogenicity; Immunological memory; Interleukin 2; Interleukin 5; Lymphocytes; Lymphocytes B; Lymphocytes T; Male; Memory cells; mRNA; multidisciplinary; SARS-CoV-2 - immunology; Science; Science (multidisciplinary); T-Lymphocytes - immunology; T-Lymphocytes - metabolism; Vaccination - methods; Vaccines; γ-Interferon